Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
Dalbavancin (Biosearch Italia/Versicor)Matthias Steiert, Franz-Josef SchmitzAntimicrobial Agents and Chemotherapy|February 26, 2004
In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinantsAd C Fluit, Franz-Josef Schmitz, Jan Verhoef, et al.American Journal of Infection Control|August 5, 2004
Experimental study on the safety of a new connecting deviceMatthias Trautmann, Stephanie Moosbauer, Franz-Josef Schmitz, et al.International Journal of Antimicrobial Agents|June 15, 2004
Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001Michael Kresken, Dieter Hafner, Franz-Josef Schmitz, et al.The Journal of Antimicrobial Chemotherapy|January 30, 2002
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureusFranz-Josef Schmitz, Mechthild Boos, Susanne Mayer, et al.The Journal of Antimicrobial Chemotherapy|March 23, 2002
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycinFranz-Josef Schmitz, Jasmina Petridou, Harold Jagusch, et al.The Journal of Antimicrobial Chemotherapy|June 1, 2002
Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolonesRalf René Reinert, Adnan Al-Lahham, Rudolf Lütticken, et al.Microbial Drug Resistance (Larchmont, N.Y.)|October 5, 2002
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773Franz-Josef Schmitz, Jasmina Petridou, Nadine Astfalk, et al.GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infectionsChristian Eckmann, Rainer Isenmann, Peter Kujath, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 4, 2023
The effect of mogamulizumab on the aberrant T cell population in the peripheral blood - A monocentric retrospective analysisJanika Gosmann, Annette Bielefeld, Franz-Josef Schmitz, et al.Pageof 2